Literature DB >> 22483260

Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men.

Jonathan Golledge1, Paula Clancy, Bu B Yeap, Graeme J Hankey, Paul E Norman.   

Abstract

BACKGROUND: Angiopoietin-2 (Angpt2) has been implicated in the mediation and regulation of angiogenesis and inflammation which are believed to be critical mechanisms in the pathogenesis of both abdominal aortic aneurysm (AAA) and cardiovascular events. The aim of this study was to assess whether serum Angpt2 was associated with the prevalence of AAA and the occurrence of cardiovascular mortality in older men.
METHODS: A cohort of 997 elderly men was recruited in 1996-99. Aortic ultrasound identified an AAA in 308 (31%). In 2001-04, blood was collected and serum Angpt2 later measured by immunoassay. The association of Angpt2 with AAA was assessed using multiple regression analysis. All men were followed by means of the Western Australia Data Linkage System until July 31st 2009. The association of Angpt2 with cardiovascular mortality was assessed using Cox proportional hazard analysis.
RESULTS: Median serum Angpt2 was significantly higher (3.16 ng/ml, inter-quartile range 2.51-4.54) in men with AAA compared with men without AAA (2.70 ng/ml, inter-quartile range 2.03-3.72; p<0.001). After adjusting for cardiovascular risk factors, men with serum Angpt2 in the highest quartile (>3.95 ng/ml) had a 2.57-fold (95% CI 1.66-3.97, p<0.001) increased odds of AAA and a 4.12-fold (95% CI 1.90-8.94, p<0.001) increased relative risk of cardiovascular mortality compared to men with serum Angpt2 in the lowest quartile (<2.13 ng/ml).
CONCLUSIONS: Serum Angpt2 is elevated in men with AAA and associated with an increased risk of cardiovascular mortality in older men.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Abdominal aortic aneurysm; Angiopoietin-2; Cardiovascular deaths

Mesh:

Substances:

Year:  2012        PMID: 22483260     DOI: 10.1016/j.ijcard.2012.03.120

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Association of carotid atherosclerosis and stiffness with abdominal aortic aneurysm: The atherosclerosis risk in communities (ARIC) study.

Authors:  Lu Yao; Aaron R Folsom; Alvaro Alonso; Pamela L Lutsey; James S Pankow; Weihua Guan; Susan Cheng; Frank A Lederle; Weihong Tang
Journal:  Atherosclerosis       Date:  2018-02-04       Impact factor: 5.162

2.  Circulating growth factors and cardiac remodeling in the community: The Framingham Heart Study.

Authors:  Cecilia Castro-Diehl; Rebecca J Song; Douglas B Sawyer; Kai C Wollert; Gary F Mitchell; Susan Cheng; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  Int J Cardiol       Date:  2021-01-07       Impact factor: 4.164

3.  Associations of Angiopoietins With Heart Failure Incidence and Severity.

Authors:  Brandon S Peplinski; Brian A Houston; David A Bluemke; Steven M Kawut; Todd M Kolb; Richard A Kronmal; Joao A C Lima; David D Ralph; Samuel G Rayner; Zachary L Steinberg; Ryan J Tedford; Peter J Leary
Journal:  J Card Fail       Date:  2021-04-17       Impact factor: 6.592

4.  Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.

Authors:  Thomas L Theelen; Jari P Lappalainen; Judith C Sluimer; Erika Gurzeler; Jack P Cleutjens; Marion J Gijbels; Erik A L Biessen; Mat J A P Daemen; Kari Alitalo; Seppo Ylä-Herttuala
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

5.  Efficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial.

Authors:  Nicola W Burton; Zanfina Ademi; Stuart Best; Maria A Fiatarone Singh; Jason S Jenkins; Kenny D Lawson; Anthony S Leicht; Yorgi Mavros; Yian Noble; Paul Norman; Richard Norman; Belinda J Parmenter; Jenna Pinchbeck; Christopher M Reid; Sophie E Rowbotham; Lisan Yip; Jonathan Golledge
Journal:  BMC Public Health       Date:  2016-11-09       Impact factor: 3.295

6.  Angiopoietin-2 attenuates angiotensin II-induced aortic aneurysm and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Hongyou Yu; Corey S Moran; Alexandra F Trollope; Lynn Woodward; Robert Kinobe; Catherine M Rush; Jonathan Golledge
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

7.  Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy.

Authors:  L O Brandenburg; C A Mueller; Christian Blume; M F Geiger; M Müller; H Clusmann; V Mainz; J Kalder
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

8.  Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden.

Authors:  David M Charytan; Angeles Cinelli; Elisabeth M Zeisberg
Journal:  Fibrogenesis Tissue Repair       Date:  2015-07-21

9.  Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI.

Authors:  Wen Jian; Lang Li; Xiao-Min Wei; Cheng-Qiang Wu; Chun Gui
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.